human
respiratori
tract
infect
repres
major
public
health
problem
associ
high
rate
hospit
signific
morbid
mortal
thu
caus
consider
financi
burden
healthcar
system
throughout
world
elderli
immunocompromis
subject
medic
condit
especi
high
risk
develop
sever
cours
infect
variou
complic
common
respiratori
virus
influenza
viru
type
iva
b
ivb
respiratori
syncyti
viru
type
rsva
b
rsvb
parainfluenza
viru
type
human
rhinovirus
hrv
human
metapneumovirus
hmpv
adenovirus
adv
human
coronavirus
hcov
human
bocaviru
hbov
enterovirus
ev
et
al
infecti
respiratori
diseas
caus
differ
virus
character
wide
rang
similar
respiratori
symptom
mild
cold
sever
pneumonia
make
clinic
distinct
differ
agent
involv
infect
difficult
although
high
rate
infect
one
respiratori
viru
report
especi
children
tabl
real
number
coinfect
undoubtedli
underestim
mainli
due
sensit
diagnost
method
use
limit
number
test
virus
major
case
like
casual
viral
agent
test
first
diagnost
stop
detect
primari
relev
infecti
agent
meanwhil
rapid
reliabl
accur
identif
everi
viral
pathogen
involv
infect
crucial
patient
manag
surveil
control
infect
includ
prevent
nosocomi
transmiss
widespread
use
pcrbase
method
excel
sensit
specif
contribut
great
improv
diagnost
respiratori
infect
singl
pcr
assay
enabl
detect
one
target
multiplex
molecular
method
provid
simultan
detect
multipl
virus
singl
reaction
thu
give
accur
diagnosi
caus
pathogen
provid
better
understand
etiolog
infect
main
advantag
use
multiplex
reaction
time
save
reduc
use
reagent
specimen
consequ
cost
analysi
seeplex
rv
detect
kit
seegen
inc
korea
use
studi
qualit
multiplex
assay
detect
respiratori
virus
includ
type
rna
one
type
dna
viru
iva
ivb
rsva
rsvb
hrv
hmpv
adv
hcov
combin
hcov
assay
use
dual
prime
oligonucleotid
dpotm
technolog
prevent
nonspecif
amplif
gener
consist
high
specif
block
extens
nonspecif
prime
templat
primer
design
highli
conserv
region
viral
genom
epidem
season
nation
influenza
centr
poland
receiv
specimen
paid
diagnost
hospit
patient
respiratori
tract
infect
includ
specimen
sever
case
ie
patient
intens
care
unit
pneumonia
respiratori
failur
immunocompromis
patient
major
specimen
hospit
requir
detect
influenza
virus
iva
ivb
n
iva
subtyp
n
test
specimen
influenza
also
respiratori
virus
commiss
patient
case
multiplex
seeplextm
ace
detect
kit
use
detect
respiratori
virus
paper
present
five
case
multipl
infect
caus
variou
respiratori
virus
immunocompromis
patient
respiratori
specimen
nasopharyng
swab
suspend
physiolog
salin
solut
within
sever
hour
sampl
collect
viral
nucleic
acid
extract
sampl
use
qiaamp
viral
rna
mini
kit
qiagen
germani
accord
manufactur
instruct
elut
perform
elut
buffer
cdna
synthes
use
first
strand
cdna
synthesi
kit
random
hexam
primer
fermenta
lithuania
revers
transcript
reaction
perform
final
volum
random
hexam
water
total
nucleic
acid
extract
clinic
specimen
rt
buffer
dntp
mix
mm
ribolocktm
rnase
inhibitor
mmulv
revers
transcriptas
incub
min
revers
transcript
reaction
carri
min
follow
inactiv
revers
transcriptas
min
next
step
multiplex
reaction
use
seeplextm
ace
detect
kit
seegen
inc
korea
contain
b
set
primer
panel
perform
reaction
volum
accord
suppli
protocol
intern
amplif
control
detect
inhibitor
pcr
posit
control
mixtur
pathogen
intern
control
clone
manufactur
templat
neg
control
steril
water
instead
templat
includ
reaction
amplif
obtain
pcr
product
analyz
electrophoresi
agaros
gel
stain
gelredtm
solut
respiratori
virus
identifi
comparison
amplicon
band
includ
posit
control
molecular
size
marker
set
b
provid
manufactur
consist
seven
band
length
pcr
product
intern
control
six
appropri
virus
result
posit
influenza
type
b
confirm
analysi
onestep
realtim
rtpcr
assay
accord
cdc
rrtpcr
protocol
version
posit
influenza
test
realtim
readi
influenza
detect
set
roch
diagnost
switzerland
use
primer
set
detect
type
specimen
laboratori
result
indic
rsv
orand
rsvb
confirm
onestep
rtpcr
use
transcriptor
onestep
rtpcr
kit
roch
diagnost
switzerland
primer
tgttataggcatatcattga
ttaaccagcaaagtgttaga
describ
et
al
amplif
carri
reaction
volum
includ
transcriptor
buffer
primer
enzym
extract
templat
water
final
volum
cycl
reaction
perform
thermal
cycler
appli
biosystem
inc
usa
follow
singl
cycl
revers
transcript
min
revers
transcriptas
inactiv
initi
denatur
min
cycl
denatur
anneal
extens
last
cycl
reaction
complet
final
extens
min
amplif
product
separ
agaros
gel
stain
gelredtm
solut
tae
buffer
generulertm
bp
dna
ladder
use
estim
molecular
size
weight
obtain
band
fermenta
lithuania
clinic
specimen
isol
nucleic
acid
cdna
store
ten
respiratori
specimen
posit
least
one
respiratori
viru
singl
infect
found
five
case
caus
iva
three
case
rsvb
two
case
coinfect
infect
two
virus
found
five
patient
doubl
infect
identifi
two
case
one
patient
coinfect
four
differ
viral
pathogen
two
patient
multipl
infect
caus
five
viral
agent
detect
tabl
show
pathogen
involv
multipl
infect
four
coinfect
patient
hospit
hospit
depart
swab
collect
march
patient
march
patient
patient
hospit
anoth
hospit
swab
collect
februari
five
patient
immunosuppress
includ
one
child
boy
differ
underli
chronic
diseas
tabl
two
patient
coinfect
caus
iva
ivb
three
virus
develop
symptom
acut
respiratori
infect
sign
bronchial
obtur
requir
longer
antivir
therapi
one
mechan
ventil
day
condit
remain
patient
medium
good
three
patient
receiv
oseltamivir
one
oseltamivir
zanamivir
one
patient
receiv
antibiot
antivir
drug
condit
two
patient
therapi
medium
although
one
receiv
oseltamivir
patient
mix
infect
five
viral
agent
iva
ivb
rsva
rsvb
confirm
monoplex
pcr
differ
primer
set
detect
iva
ivb
rsvab
without
identif
subtyp
show
result
consist
multiplex
seeplex
pcr
case
patient
second
specimen
bronchoalveolar
lavag
collect
march
result
posit
rsvb
neg
pathogen
includ
iva
rsva
detect
previou
specimen
convent
method
diagnost
viral
respiratori
infect
base
mainli
viru
isol
cell
cultur
antigen
detect
serolog
assay
cell
cultur
consid
gold
standard
viru
diagnosi
adapt
medic
import
respiratori
virus
contrast
method
pcr
permit
rapid
detect
virus
difficult
cultur
well
replic
vitro
hmpv
hcov
hrv
excel
sensit
specifi
calvo
et
al
addit
virus
present
specimen
may
consider
differ
viral
load
rate
replic
would
make
detect
slowli
replic
pathogen
difficult
therefor
numer
studi
develop
recent
year
evalu
pcrbase
method
detect
typingsubtyp
respiratori
virus
templeton
et
al
bellaupujol
et
al
gunson
et
al
wu
et
al
viral
infect
taken
consider
similar
nonspecif
clinic
symptom
caus
variou
respiratori
virus
list
possibl
etiolog
agent
long
contrast
monoplex
pcr
reaction
use
multiplex
pcr
allow
detect
variou
respiratori
pathogen
singl
reaction
includ
identif
type
detect
coinfect
multipl
agent
could
miss
monoplex
reaction
introduct
multiplex
pcr
routin
diagnost
reveal
higher
preval
coinfect
previous
report
convent
techniqu
freymuth
et
al
review
literatur
indic
rate
coinfect
may
rang
approxim
high
posit
specimen
tabl
major
paper
present
result
molecular
assay
simultan
detect
respiratori
virus
mix
infect
focu
pediatr
patient
infant
young
children
viral
shed
respiratori
tract
usual
much
higher
patient
respiratori
syncyti
virus
common
pathogen
occur
respiratori
viral
coinfect
next
often
identifi
virus
mix
infect
hrv
piv
hmpv
other
also
observ
coinfect
differ
subtyp
influenza
viru
pajak
et
al
seeplextm
rv
detect
kit
recent
found
good
tool
detect
multipl
infect
caus
common
respiratori
virus
yoo
et
al
et
al
sensit
higher
viral
cultur
assay
drew
et
al
roh
et
al
kim
et
al
lee
et
al
find
confirm
coinfect
rare
occurr
particularli
immunocompromis
patient
medic
condit
receiv
immunosuppress
therapi
nevertheless
limit
studi
low
number
test
specimen
specimen
allow
make
signific
observ
especi
comparison
clinic
epidemiolog
featur
patient
singl
infect
patient
multipl
infect
rapid
accur
identif
etiolog
agent
involv
respiratori
infect
essenti
clinic
valu
may
support
physician
decis
regard
select
appropri
treatment
prompt
use
antivir
drug
neuraminidas
inhibitor
case
influenza
infect
patient
expos
famili
member
contact
person
clinician
inclin
use
antibiot
case
etiolog
agent
infect
identifi
therefor
spite
lack
specif
antivir
drug
symptomat
support
treatment
major
respiratori
viral
infect
rapid
detect
viral
pathogen
may
help
avoid
inappropri
use
antibiot
moreov
multiplex
method
enabl
detect
broad
spectrum
common
viral
pathogen
clinic
desir
case
specif
group
patient
children
elderli
immunocompromis
individu
tend
prolong
viru
shed
increas
risk
seriou
complic
mortal
test
allow
detect
agent
primarili
expect
patient
anoth
import
aspect
identif
mix
infect
presenc
one
pathogen
may
influenc
cours
infect
although
exact
clinic
signific
mix
infect
remain
unclear
et
al
numer
studi
describ
coinfect
clinic
differ
among
patient
singl
multipl
infect
report
includ
sever
diseas
clinic
sign
infect
intens
durat
hospit
stay
brouard
et
al
lee
et
al
nascimento
et
al
contrast
calvo
et
al
report
infant
coinfect
rsv
one
respiratori
pathogen
significantli
higher
incid
fever
durat
hospit
longer
comparison
infant
infect
rsv
studi
richard
et
al
signific
correl
dual
viral
infect
increas
sever
bronchiol
found
infant
coinfect
time
higher
risk
admiss
pediatr
intens
care
unit
singl
infect
signific
factor
bore
sever
infect
age
day
prematur
birth
underli
chronic
diseas
statist
signific
differ
host
condit
durat
assist
ventil
supplement
oxygen
administr
durat
hospit
richard
et
al
certainli
studi
better
understand
variou
interact
clinic
differ
singl
multipl
respiratori
viral
infect
need
carri
brunstein
et
al
suggest
occurr
pathogen
cosuppress
infect
one
pathogen
reduc
risk
infect
other
interact
observ
follow
virus
rsv
iv
rsva
rsvb
rsv
piv
hrv
rsviv
howev
present
studi
identifi
four
case
simultan
infect
rsv
iv
two
case
caus
rsva
rsvb
one
type
rsv
piv
four
coinfect
patient
hospit
unit
multipl
infect
caus
four
differ
combin
six
virus
iva
four
patient
ivb
two
patient
rsva
four
patient
rsvb
three
patient
hcov
two
patient
one
patient
specimen
collect
week
suggest
high
probabl
nosocomi
transmiss
addit
case
patient
second
specimen
collect
interv
day
neg
iva
rsva
posit
rsvb
present
studi
limit
electrophoret
gel
pattern
pcr
product
obtain
patient
coinfect
intens
band
variabl
faint
band
due
excel
sensit
pcr
low
detect
limit
even
sever
copi
per
reaction
includ
nonrepl
virus
weak
posit
result
may
relat
activ
pass
infect
calvo
et
al
especi
children
immunosuppress
patient
shed
low
concentr
virus
previou
infect
would
expect
may
relev
interpret
multipl
infect
role
particular
pathogen
clinic
pictur
diseas
identifi
presenc
viral
agent
exclud
possibl
concomit
infect
caus
bacteri
pathogen
studi
patient
cultur
bronchial
secret
sputum
gave
neg
result
patient
cultur
bronchial
secret
posit
acinetobact
baumanii
patient
posit
streptococcu
pneumonia
throat
swab
neg
conclus
find
show
case
hospit
patient
respiratori
tract
infect
especi
sever
infect
observ
children
elderli
immunocompromis
patient
suscept
seriou
complic
simultan
detect
multipl
viral
agent
advis
reliabl
detect
influenza
virus
enabl
reveal
accur
pictur
diseas
thu
essenti
control
infect
includ
nosocomi
transmiss
priorit
diagnost
improv
prevent
therapeut
manag
identifi
accur
etiolog
infect
also
allow
physician
determin
better
prognosi
inform
patient
measur
implement
limit
spread
infect
person
